News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current LABP market cap is 67.79M. The company's latest EPS is USD -7.0378 and P/E is -3.09.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.83M | -6.51M | -6.48M | -4.44M | -5.2M |
| Net Income | -7.9M | -5.23M | -6.03M | -3.92M | -5.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 18M | 0 | 0 |
| Operating Income | -13.29M | -30.68M | -38.82M | -40.56M | -22.73M |
| Net Income | -13.47M | -30.14M | -38.42M | -39.28M | -21.94M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 49.49M | 45.25M | 51.18M | 46.29M | 43.23M |
| Total Liabilities | 5.48M | 6.12M | 4.16M | 3.02M | 5.57M |
| Total Equity | 44.01M | 39.13M | 47.02M | 43.27M | 37.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 50.48M | 30.33M | 92.88M | 45.25M | 38.04M |
| Total Liabilities | 3.03M | 11.31M | 16.61M | 6.12M | 6.25M |
| Total Equity | -25.58M | -54.02M | 76.27M | 39.13M | 31.79M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -42.07M | -45.77M | -8.17M | -13.28M | -15.51M |
| Investing | 62.59M | 74.06M | 3.1M | 7.08M | 7.71M |
| Financing | N/A | N/A | 13.67M | 13.57M | 13.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.87M | -22.96M | -27.06M | -45.77M | -20.48M |
| Investing | -40.33M | 14.13M | -58.71M | 74.06M | 7.78M |
| Financing | 59.65M | 1.52M | 91.61M | N/A | 13.57M |
| Market Cap | 67.79M |
| Price to Earnings Ratio | -3.09 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.81 |
| Price to Book Ratio | 2.13 |
| Dividend Yield | - |
| Shares Outstanding | 3.12M |
| Average Volume (1 week) | 15.3k |
| Average Volume (1 Month) | 56.48k |
| 52 Week Change | 601.84% |
| 52 Week High | 21.95 |
| 52 Week Low | 2.50 |
| Spread (Intraday) | 1.35 (5.88%) |
| Company Name | Landos Biopharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.landosbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
